| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROTAMINE SULFATE | 624 | 0.3391 |
| 1 | DARUNAVIR ETHANOLATE AND COBICISTAT | 377 | 0.2140 |
| 2 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1636 | 0.1824 |
| 3 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE | 1219 | 0.1812 |
| 4 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 604 | 0.1680 |
| 5 | GADOXETATE DISODIUM | 74 | 0.1678 |
| 6 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1570 | 0.1563 |
| 7 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 1701 | 0.1489 |
| 8 | ATAZANAVIR AND COBICISTAT | 36 | 0.1469 |
| 9 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 251 | 0.1423 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 7567 | 0.0687 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 3791 | 0.0627 |
| 2 | Osmotic Diuretic [EPC] | 312 | 0.0597 |
| 3 | Antidiarrheal [EPC] | 12 | 0.0502 |
| 4 | Paramagnetic Contrast Agent [EPC] | 227 | 0.0494 |
| 5 | Protease Inhibitor [EPC] | 1696 | 0.0381 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1456 | 0.0296 |
| 7 | CCR5 Co-receptor Antagonist [EPC] | 62 | 0.0270 |
| 8 | alpha-Hydroxy Acid [EPC] | 52 | 0.0238 |
| 9 | Provitamin D2 Compound [EPC] | 701 | 0.0236 |